Meridian Bioscience, Inc. Reports First Quarter 2013 Operating Results and Reaffirms Fiscal 2013 Guidance
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
• reported record first quarter net sales of $45.4 million, an increase of 13%, from the same period of the prior fiscal year; • reported first quarter operating income of $13.1 million, an increase of 34%, over the same period of the prior fiscal year; • reported first quarter net earnings of $8.5 million, or $0.20 per diluted share, increases of 29% and 25%, respectively, compared to the fiscal 2012 first quarter.
• reported record first quarter net sales of $45.4 million, an increase of 13%, from the same period of the prior fiscal year; • reported first quarter operating income of $13.1 million, an increase of 34%, over the same period of the prior fiscal year; • reported first quarter net earnings of $8.5 million, or $0.20 per diluted share, increases of 29% and 25%, respectively, compared to the fiscal 2012 first quarter.